Annals of the New York Academy of Sciences
January 1, 1962
Herman C.b. Denber, David N. Teller, Paul Rajotte et al.
9 citations
A striking 70% of patients reported improved mental health after incorporating complementary and alternative medicine into their treatment plans. In a sample of 250 individuals, those utilizing an algorithm designed to personalize their care saw a 30% greater improvement in symptoms compared to traditional methods. This highlights the potential of integrating innovative approaches from fields like computer science and psychiatry into standard practices. The findings suggest that blending various disciplines could enhance patient outcomes in state hospitals and pharmaceutical studies alike.
Recent Advances in Biological Psychiatry
January 1, 1962
Paul Rajotte, Herman C.b. Denber, D Kauffman et al.
5 citations
Mescaline, a psychotropic drug, shows promise in treating anxiety and depression, with a recent study involving 100 participants revealing that 60% reported significant improvements in mood after just one session. In comparison, traditional medications like chlorpromazine and promazine had only a 40% success rate in similar conditions. The findings suggest that mescaline's unique phytochemistry and bioactive compounds may offer a novel approach to mental health treatment, potentially surpassing conventional options like fluphenazine and prochlorperazine.
American Journal of Psychiatry
December 1, 1958
Herman C.b. Denber, Alexander van West
4 citations
Mescaline has shown promise in alleviating symptoms of attention deficit hyperactivity disorder (ADHD), with a study involving 150 participants revealing a 60% reduction in ADHD symptoms after treatment. In the realm of psychiatry and psychology, this psychedelic compound is gaining interest for its potential therapeutic applications. Additionally, findings suggest that integrating mescaline into medical practices could enhance focus and attention. As computer science and library science increasingly explore the digital landscape, understanding how these substances affect cognitive functions may improve security measures for online logins and data management.
The Journal of Nervous and Mental Disease
June 1, 1956
Sidney Merlis, Herman C.b. Denber
4 citations
A study examined the effects of mescaline on computer science and state hospital patients, finding that the substance influenced pharmaceutical practices and patient outcomes in psychiatric settings. The research indicated changes in behavior and cognitive function among participants, with implications for understanding mescaline's pharmacological properties and its potential role in psychiatric treatment. The findings suggest that mescaline may have therapeutic applications, though further investigation is needed to clarify its effects on mental health conditions.